| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |